SCHEMBL24460610

SCHEMBL24460610

Cc1cccc2ccc3[nH]ncc3c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.46
▸ NOS1 P29475 4/20 0.44
▸ AXL P30530 2/20 0.44
▸ TRPA1 O75762 1/20 0.43
▸ CDK2 P24941 6/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ METAP2 P50579 2/20 0.41
▸ FLT3 P36888 5/20 0.40
▸ CCNA1 P78396 5/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ STING1 Q86WV6 1/20 0.38
▸ MET P08581 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24460593 0.79 NOS1 (0.62) IDO1NOS1AXLTRPA1CDK2
SCHEMBL29563432 0.79 NOS1 (0.62) IDO1NOS1AXLTRPA1CDK2
SCHEMBL12141 0.77 IDO1 (0.60) IDO1NOS1AXLTRPA1CDK2
SCHEMBL29563426 0.72 IDO1 (0.54) IDO1NOS1AXLTRPA1CDK2
SCHEMBL276443 0.72 IDO1 (0.54) IDO1NOS1AXLTRPA1CDK2
SCHEMBL15730306 0.71 NOS1 (0.43) IDO1NOS1AXLTRPA1CDK2
SCHEMBL12315709 0.70 METAP2 (0.64) IDO1NOS1AXLTRPA1CDK2
SCHEMBL15045468 0.70 MAPT (0.43) ALDH1A1CYP3A4HPGDTSHRHSD17B10
SCHEMBL8404436 0.70 IDO1 (0.46) IDO1NOS1AXLTRPA1CDK2
SCHEMBL12321248 0.70 NOS1 (0.56) IDO1NOS1AXLTRPA1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109485-A1 6,7-DIHYDRO-PYRANO[2,3-D]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT MERCK SHARP & DOHME CORP. (US) 2022-05-27 — — WO disclosed
Send feedback